ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients

Fondazione EMN Italy Onlus · 2008
ClinicalTrials.gov · Datasets · License: Public Domain · 2008
Open Source ↗
overall-survivalprogression-free-survival
myeloma, relapsed/refractory myeloma patients, progression free survival, overall survival, dasatinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810571
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.